scholarly article | Q13442814 |
P50 | author | Xabier Marichalar-Mendia | Q53171873 |
P2093 | author name string | A Mosqueda-Taylor | |
N G Bediaga | |||
J M Aguirre-Urizar | |||
A Setién-Olarra | |||
P Aguirre-Echebarria | |||
P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma | Q24646667 | ||
Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update | Q28072830 | ||
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma | Q28259466 | ||
High frequency of BRAF V600E mutations in ameloblastoma | Q28304785 | ||
Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR | Q30984776 | ||
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes | Q33343251 | ||
HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. | Q33508982 | ||
LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor | Q33550560 | ||
MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer. | Q53369992 | ||
Genomewide miRNA profiling of oral lichenoid disorders and oral squamous cell carcinoma | Q60475683 | ||
Effects of miR-31 on the osteogenesis of human mesenchymal stem cells | Q87351761 | ||
miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung | Q95352404 | ||
Microgenomics of ameloblastoma | Q33808215 | ||
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). | Q34130721 | ||
EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma | Q34208077 | ||
Ameloblastoma: biological profile of 3677 cases | Q34302005 | ||
Ameloblastomas: clinicopathological features from 70 cases diagnosed in a single oral pathology service in an 8-year period | Q34654079 | ||
Novel functions and targets of miR-944 in human cervical cancer cells | Q34776143 | ||
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer | Q34793233 | ||
Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells | Q34980886 | ||
ΔNp63 intronic miR-944 is implicated in the ΔNp63-mediated induction of epidermal differentiation | Q36002522 | ||
How microRNAs control cell division, differentiation and death | Q36229101 | ||
MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer | Q36430771 | ||
MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). | Q36725131 | ||
MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers | Q36822387 | ||
MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma | Q36863089 | ||
Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells. | Q37066995 | ||
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth | Q37109741 | ||
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma | Q37160342 | ||
Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis | Q37190115 | ||
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. | Q37279318 | ||
miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma | Q37482708 | ||
Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeutics | Q38246499 | ||
Novel targets for the treatment of ameloblastoma | Q38271523 | ||
An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A). | Q38771776 | ||
GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion | Q38797904 | ||
Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12. | Q38891981 | ||
Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer | Q38911896 | ||
Activating FGFR2-RAS-BRAF mutations in ameloblastoma. | Q38978265 | ||
Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature | Q39103785 | ||
MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells | Q39792870 | ||
miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling | Q42173434 | ||
Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. | Q46434900 | ||
Allelic loss of tumor suppressor genes in ameloblastic tumors | Q47631858 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | e0186841 | |
P577 | publication date | 2017-10-20 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | MicroRNAs expression profile in solid and unicystic ameloblastomas | |
P478 | volume | 12 |
Search more.